Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERIBULIN vs PACLITAXEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERIBULIN vs PACLITAXEL: Safety Overview

Metric ERIBULIN PACLITAXEL
Total FAERS Reports 5,055 77,334
Deaths Reported 793 12,030
Death Rate 15.7% 15.6%
Hospitalizations 2,642 31,638
Average Patient Age 57.3 yrs 60.3 yrs
% Female Patients 93.0% 69.4%
FDA Approval Date Apr 5, 2024 Apr 10, 2025
Manufacturer Gland Pharma Limited Gland Pharma Limited
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued